key: cord-0787604-uejtkfe7
authors: Qin, Geng; Yang, Jie; Zhao, Chuanqi; Ren, Jinsong; Qu, Xiaogang
title: The COVID-19 susceptibility of cancer patients might due to the high expression of SARS-CoV-2 required host factors
date: 2021-12-22
journal: J Infect
DOI: 10.1016/j.jinf.2021.12.011
sha: 1acc729816c59c4412a97c53a5141a25218be66e
doc_id: 787604
cord_uid: uejtkfe7

nan

Geng Qin 1,2 , Jie Yang 1,2 , Chuanqi Zhao 1,2 , Jinsong Ren 1 In this study, we investigated the expression patterns of all 37 SARS-CoV-2 required host factors in 31 available cancer types in the TCGA pan-cancer database from GEPIA [5] to explain the potential reasons why cancer patients have higher risks of SARS-CoV-2 infection and severe outcomes. We found that the SARS-CoV-2 required host factors are significant up-regulated in the majority of cancer types (Fig.   1) , especially in Lymphoid Neoplasm Diffuse Large B-cell Lymphoma (DLBC), Pancreatic adenocarcinoma (PAAD), Thymoma (THYM), Cholangiocarcinoma (CHOL), suggesting the high expression of these factors may increase the risk of SARS-CoV-2 infection in cancer patients. In contrast, many of these factors expression were decreased in female genital cancers (Fig. 1) , which is consistent with the prior report that patients with female genital cancers show relatively low risks of SARS-CoV-2 infection [6] .

It has been shown that patients with late-stage cancer have higher risks of SARS-CoV-2 infection and a more severe COVID-19 trajectory. Thus, we analyzed the correlation between these factors expression and the tumor stage in human pan-cancer. Among all the 37 factors, the high expression levels of 24 factors were found to be correlated significantly with late pathological stage (Fig. 2) , suggesting that the COVID-19 susceptibility of patients with late-stage cancer may due to the high expression of SARS-CoV-2 required host factors.

In summary, the up-regulation of the required host factors for SARS-COV-2 infection in tumor tissues made cancer patients more likely to be infected by SARS-COV-2. We also suggested that most of these factors expression in tumor tissues increases with tumor stage, which may be one of the underlying mechanisms mediating the high risks of SARS-CoV-2 infection and severe outcomes observed in patients with late-stage cancer. We provided new insights into the biological linkage between SARS-CoV-2 and cancer. We hoped that our findings will help develop novel therapies for all patients with COVID-19. 

COVID-19 and Cancer: Current Challenges and Perspectives

Which cancer type has the highest risk of COVID-19 infection?

The high expression of SARS-CoV-2 cell receptors might lead to higher COVID-19 infection rates in cancer patients

Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study